This study presents IRON, an integrative radiogenomic framework to predict the volumetric response of heterogeneous, multi-site ovarian cancer to NACT. The framework uses two…
Browsing: Ovarian Cancer
Fujitsu, Takeda Pharmaceutical Company Limited, and the National Cancer Center Japan have conducted a joint research project to analyze patient journeys of ovarian cancer…
Lantern Pharma Inc. (NASDAQ: LTRN), a biopharmaceutical company utilizing its proprietary RADR AI and ML platform to revolutionize the cost, speed, and timeline of…